Methamnetamine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Methamnetamine
Methamnetamine structure.png
Legal status
Legal status
Identifiers
PubChem CID
ChemSpider
Chemical and physical data
FormulaC14H17N
Molar mass199.297 g·mol−1
3D model (JSmol)

Methamnetamine (also known as methylnaphetamine, MNA, MNT and PAL-1046) is a triple monoamine releasing agent and N-methyl analog of the non-neurotoxic experimental drug naphthylaminopropane and the naphthalene analog of methamphetamine.[1] It has been sold online as a designer drug.[2][3]

It acts as a releasing agent of serotonin, norepinephrine, and dopamine, with EC50 values of 13 nM, 34 nM, and 10 nM, respectively.[1]

Legal status[edit]

Methamnetamine is illegal in Japan.[4]

See also[edit]

References[edit]

  1. ^ a b Rothman RB, Partilla JS, Baumann MH, Lightfoot-Siordia C, Blough BE (April 2012). "Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters". The Journal of Pharmacology and Experimental Therapeutics. 341 (1): 251–62. doi:10.1124/jpet.111.188946. PMC 3364510. PMID 22271821.
  2. ^ "Methamnetamine". WEDINOS.
  3. ^ "Methamnetamine". New Synthetic Drugs Database.
  4. ^ "指定薬物名称・構造式一覧(平成27年9月16日現在)" (PDF) (in Japanese). 厚生労働省. 16 September 2015. Retrieved 8 October 2015.